Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2024 financial results and provided a corporate update.